Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

China Shineway Pharmaceutical Group Limited, Healthcare & Pharm

HONG KONG, June 2, 2021 - (ACN Newswire) - UOB-Kay Hian issued a report raising the target price of China Shineway Pharmaceutical (02877.HK) from HK$8.44 to HK$11.8, an increase of 39.8%, on a BUY rating.

02.06.2021 - 02:13:42

UOB-Kay Hian raises Shineway Pharm target to HK$11.8. China Shineway Pharmaceutical 1Q21 revenue was RMB 744 million, surging 37% YoY. All business segments continued to experience robust recovery.



Copyright 2021 ACN Newswire . All rights reserved.
@ japancorp.net